ğŸ§  Agent Workflow
	1.	Agent 1 â€“ Keyword Extractor
â¤ Extracts relevant biomedical keywords from the userâ€™s question.
	2.	Agent 2 â€“ PubMed Retriever
â¤ Uses those keywords to fetch top 10 relevant papers from PubMed.
	3.	Agent 3 â€“ Chunk Selector
â¤ Applies RAG-style retrieval to select the 5 most relevant text chunks.
	4.	Agent 4 â€“ Answer Generator
â¤ Generates a concise, cited answer using the chunks and original question.
	5.	Agent 5 â€“ Answer Refiner
â¤ Improves the answer for clarity, completeness, and factual accuracy.

â¸»

ğŸ—‚ï¸ File Structure

biomed-qa/
â”œâ”€â”€ agent1.py         # Keyword extractor
â”œâ”€â”€ agent2.py         # PubMed fetcher
â”œâ”€â”€ agent3.py         # RAG chunk retriever
â”œâ”€â”€ agent4.py         # Answer generator
â”œâ”€â”€ agent5.py         # Self-critic and refiner
â”œâ”€â”€ main.py           # Entry point to run the full pipeline
â”œâ”€â”€ requirements.txt  # Required Python packages
â””â”€â”€ README.md         # This file

â¸»

ğŸš€ How to Run
	1.	Create Environment

conda create -n biomed python=3.10
conda activate biomed
pip install -r requirements.txt
	2.	Set Your OpenAI API Key

Option A â€“ set as environment variable:
export OPENAI_API_KEY=â€œyour-openai-api-keyâ€

Option B â€“ set directly in main.py:

import os
os.environ[â€œOPENAI_API_KEYâ€] = â€œyour-openai-api-keyâ€
	3.	Run the Agent Chain

python main.py

You will be prompted to enter a biomedical question, e.g.:

What are treatments for glioblastoma resistant to temozolomide?

â¸»

âœ… Example Output

ğŸ§  Extracted Keywords: glioblastoma, temozolomide, resistance
ğŸ“„ Top 10 PubMed Papers fetched
ğŸ“š Selected 5 Relevant Chunks
âœï¸ Draft Answer:
â€œGlioblastoma resistant to temozolomide can be treated withâ€¦â€
ğŸ“ Citations: [PMID:12345678], [PMID:98765432], â€¦
âœ… Final Answer (Refined): â€¦

â¸»

ğŸ“Œ Notes
	â€¢	This pipeline can be extended to other biomedical domains and LLMs.
	â€¢	Consider replacing OpenAI with open-source models for full offline deployment.

â¸»

ğŸ“– License

MIT License. See LICENSE for details.
